Efficacy and safety outcomes of multimodal endoscopic eradication therapy in Barretts esophagus-related neoplasia: a systematic review and pooled analysis
ADA 2026 Obesity Drug Updates: Retatrutide, CagriSema, and Oral GLP-1s At the 2026 American Diabetes Association Scientific Sessions, investigators unveiled a wave of late-stage obesity trial results that could reshape clinical practice
doi: 10.3389/fgene.2016.00095
While certain GLP-1 medications are approved for diabetes and weight loss by the US Food and Drug Administration (FDA), most off-label semaglutide medications are compounded GLP-1s, which are not FDA-approved
Instead, our findings demonstrate an important role for GSH in the liver, where under resting conditions, GSH maintains low NRF2 activity to permit ample expression of lipogenic enzymes, promotes the production of triglycerides, and sustains lipid abundance in vivo
Lips or fingernails turning blue is another